Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 11:52:40 UTC |
---|
Update Date | 2021-09-26 23:06:39 UTC |
---|
HMDB ID | HMDB0253439 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- |
---|
Description | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- belongs to the class of organic compounds known as quinoxalines. Quinoxalines are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring. Based on a literature review very few articles have been published on Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-. This compound has been identified in human blood as reported by (PMID: 31557052 ). Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1h-imidazol-2-yl)methyl)- is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC1=CC=CC(=N1)C1=C(N=C(CC2=CC=CC(=C2)C(N)=O)N1)C1=CC2=NC=CN=C2C=C1 InChI=1S/C25H20N6O/c1-15-4-2-7-20(29-15)24-23(17-8-9-19-21(14-17)28-11-10-27-19)30-22(31-24)13-16-5-3-6-18(12-16)25(26)32/h2-12,14H,13H2,1H3,(H2,26,32)(H,30,31) |
---|
Synonyms | Value | Source |
---|
3-((5-(6-Methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide | MeSH |
|
---|
Chemical Formula | C25H20N6O |
---|
Average Molecular Weight | 420.476 |
---|
Monoisotopic Molecular Weight | 420.169859288 |
---|
IUPAC Name | 3-{[5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl]methyl}benzamide |
---|
Traditional Name | 3-{[4-(6-methylpyridin-2-yl)-5-(quinoxalin-6-yl)-3H-imidazol-2-yl]methyl}benzamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1=CC=CC(=N1)C1=C(N=C(CC2=CC=CC(=C2)C(N)=O)N1)C1=CC2=NC=CN=C2C=C1 |
---|
InChI Identifier | InChI=1S/C25H20N6O/c1-15-4-2-7-20(29-15)24-23(17-8-9-19-21(14-17)28-11-10-27-19)30-22(31-24)13-16-5-3-6-18(12-16)25(26)32/h2-12,14H,13H2,1H3,(H2,26,32)(H,30,31) |
---|
InChI Key | RYKSGWSKILPDDY-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as quinoxalines. Quinoxalines are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazanaphthalenes |
---|
Sub Class | Benzodiazines |
---|
Direct Parent | Quinoxalines |
---|
Alternative Parents | |
---|
Substituents | - Quinoxaline
- Benzamide
- Benzoic acid or derivatives
- 2,4,5-trisubstituted-imidazole
- Trisubstituted imidazole
- Benzoyl
- Methylpyridine
- Monocyclic benzene moiety
- Benzenoid
- Pyridine
- Pyrazine
- Azole
- Heteroaromatic compound
- Imidazole
- Primary carboxylic acid amide
- Carboxamide group
- Carboxylic acid derivative
- Azacycle
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C)=C3)[NH]2)=N1 | 4266.3 | Semi standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C)=C3)[NH]2)=N1 | 4118.1 | Standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C)=C3)[NH]2)=N1 | 5587.2 | Standard polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TMS,isomer #2 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(N)=O)=C3)N2[Si](C)(C)C)=N1 | 4271.5 | Semi standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TMS,isomer #2 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(N)=O)=C3)N2[Si](C)(C)C)=N1 | 3820.3 | Standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TMS,isomer #2 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(N)=O)=C3)N2[Si](C)(C)C)=N1 | 5830.9 | Standard polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C)=C3)N2[Si](C)(C)C)=N1 | 4219.3 | Semi standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C)=C3)N2[Si](C)(C)C)=N1 | 3932.6 | Standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C)=C3)N2[Si](C)(C)C)=N1 | 5212.5 | Standard polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TMS,isomer #2 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C3)[NH]2)=N1 | 4094.0 | Semi standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TMS,isomer #2 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C3)[NH]2)=N1 | 4039.1 | Standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TMS,isomer #2 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C3)[NH]2)=N1 | 5264.6 | Standard polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,3TMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C3)N2[Si](C)(C)C)=N1 | 4113.1 | Semi standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,3TMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C3)N2[Si](C)(C)C)=N1 | 3836.7 | Standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,3TMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=C3)N2[Si](C)(C)C)=N1 | 4956.1 | Standard polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TBDMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C3)[NH]2)=N1 | 4419.8 | Semi standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TBDMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C3)[NH]2)=N1 | 4274.3 | Standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TBDMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C3)[NH]2)=N1 | 5561.1 | Standard polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TBDMS,isomer #2 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(N)=O)=C3)N2[Si](C)(C)C(C)(C)C)=N1 | 4468.9 | Semi standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TBDMS,isomer #2 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(N)=O)=C3)N2[Si](C)(C)C(C)(C)C)=N1 | 4020.8 | Standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,1TBDMS,isomer #2 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(N)=O)=C3)N2[Si](C)(C)C(C)(C)C)=N1 | 5737.5 | Standard polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TBDMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C3)N2[Si](C)(C)C(C)(C)C)=N1 | 4564.3 | Semi standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TBDMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C3)N2[Si](C)(C)C(C)(C)C)=N1 | 4277.1 | Standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TBDMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N[Si](C)(C)C(C)(C)C)=C3)N2[Si](C)(C)C(C)(C)C)=N1 | 5218.8 | Standard polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TBDMS,isomer #2 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3)[NH]2)=N1 | 4476.3 | Semi standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TBDMS,isomer #2 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3)[NH]2)=N1 | 4322.6 | Standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,2TBDMS,isomer #2 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3)[NH]2)=N1 | 5211.6 | Standard polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,3TBDMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3)N2[Si](C)(C)C(C)(C)C)=N1 | 4633.5 | Semi standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,3TBDMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3)N2[Si](C)(C)C(C)(C)C)=N1 | 4288.1 | Standard non polar | 33892256 | Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)-,3TBDMS,isomer #1 | CC1=CC=CC(C2=C(C3=CC=C4N=CC=NC4=C3)N=C(CC3=CC=CC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=C3)N2[Si](C)(C)C(C)(C)C)=N1 | 5018.3 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- GC-MS (Non-derivatized) - 70eV, Positive | splash10-0zgl-1319700000-8326f46eb20c41d7a1c1 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- 10V, Positive-QTOF | splash10-0fk9-0000900000-4befade8474cf1a24799 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- 20V, Positive-QTOF | splash10-0uk9-0001900000-47906c66ae492e936571 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- 40V, Positive-QTOF | splash10-0fb9-0019200000-3c357d865af69c9cd7ab | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- 10V, Negative-QTOF | splash10-014i-0000900000-ac34731c141788ff95f2 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- 20V, Negative-QTOF | splash10-014i-0001900000-93d06866bc8b67d49a7b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Benzamide, 3-((4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl)methyl)- 40V, Negative-QTOF | splash10-0ufu-4849100000-ae10ab29d6a43c7d6aa2 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|